Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen; Magnus Arpi; Niels Eske Bruun

Linezolid som behandling af infektiøs endokarditis

Translated title of the contribution: [Linezolid therapy for infectious endocarditis]

Trine Kiilerich Lauridsen, Magnus Arpi, Niels Eske Bruun

Department of Clinical Medicine

1 Citation (Scopus)

Abstract

In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

Translated title of the contribution	[Linezolid therapy for infectious endocarditis]
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	172
Issue number	16
Pages (from-to)	1215-6
Number of pages	2
ISSN	0041-5782
Publication status	Published - 19 Apr 2010

Cite this

@article{7f900122f46e4edd850b4987a3beca60,

title = "Linezolid som behandling af infekti{\o}s endokarditis",

abstract = "In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.",

author = "Lauridsen, {Trine Kiilerich} and Magnus Arpi and Bruun, {Niels Eske}",

year = "2010",

month = apr,

day = "19",

language = "Dansk",

volume = "172",

pages = "1215--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "16",

}

TY - JOUR

T1 - Linezolid som behandling af infektiøs endokarditis

AU - Lauridsen, Trine Kiilerich

AU - Arpi, Magnus

AU - Bruun, Niels Eske

PY - 2010/4/19

Y1 - 2010/4/19

N2 - In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

AB - In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 1215

EP - 1216

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 16

ER -

Linezolid som behandling af infektiøs endokarditis

Abstract

Fingerprint

Cite this